These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8890319)

  • 21. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different responses to opioids measured in terminals and somas of Edinger-Westphal neurons.
    Chiappinelli VA; Wolf KM; Feng C; Yum L; McMahon LL
    Neuroscience; 1993 Nov; 57(2):425-32. PubMed ID: 7509469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of NMDA-induced currents by mu-opioid receptor agonist DAGO in acutely isolated rat spinal dorsal horn neurons.
    Rusin KI; Randić M
    Neurosci Lett; 1991 Apr; 124(2):208-12. PubMed ID: 1648691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
    Baumhaker Y; Gafni M; Keren O; Sarne Y
    Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mu-Opioid agonists inhibit spinal trigeminal substantia gelatinosa neurons in guinea pig and rat.
    Grudt TJ; Williams JT
    J Neurosci; 1994 Mar; 14(3 Pt 2):1646-54. PubMed ID: 8126561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid.
    Chen L; Huang LY
    Neuron; 1991 Aug; 7(2):319-26. PubMed ID: 1678615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
    Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioidergic modulation of voltage-activated K+ currents in magnocellular neurons of the supraoptic nucleus in rat.
    Müller W; Hallermann S; Swandulla D
    J Neurophysiol; 1999 Apr; 81(4):1617-25. PubMed ID: 10200198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
    Sbacchi M; La Regina A; Petrillo P; Tavani A
    NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
    Stewart PE; Hammond DL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG; Duffy P; Kalivas PW
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioids decrease high-voltage activated calcium currents in acutely dissociated neostriatal neurons.
    Stefani A; Surmeier DJ; Bernardi G
    Brain Res; 1994 Apr; 642(1-2):339-43. PubMed ID: 8032898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid-glutamate interactions in rat locus coeruleus neurons.
    Oleskevich S; Clements JD; Williams JT
    J Neurophysiol; 1993 Sep; 70(3):931-7. PubMed ID: 7693886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mu-Opioid peptide modulation of cardiovascular and sympathoadrenal responses to stress.
    Marson L; Kiritsy-Roy JA; Van Loon GR
    Am J Physiol; 1989 Oct; 257(4 Pt 2):R901-8. PubMed ID: 2552846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-Methyl-D-aspartate attenuates opioid receptor-mediated G protein activation and this process involves protein kinase C.
    Fan GH; Zhao J; Wu YL; Lou LG; Zhang Z; Jing Q; Ma L; Pei G
    Mol Pharmacol; 1998 Apr; 53(4):684-90. PubMed ID: 9547359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mu-Opioid peptides inhibit thalamic neurons.
    Brunton J; Charpak S
    J Neurosci; 1998 Mar; 18(5):1671-8. PubMed ID: 9464992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats.
    Spencer RL; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Jul; 246(1):92-101. PubMed ID: 2839673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP; Leone P; Pocock D; Wise RA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.